A detailed history of 9258 Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, 9258 Wealth Management, LLC holds 2,561 shares of NVO stock, worth $269,058. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,561
Previous 2,589 1.08%
Holding current value
$269,058
Previous $369,000 17.62%
% of portfolio
0.05%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $3,333 - $4,071
-28 Reduced 1.08%
2,561 $304,000
Q2 2024

Aug 02, 2024

SELL
$122.71 - $146.91 $13,375 - $16,013
-109 Reduced 4.04%
2,589 $369,000
Q1 2024

May 03, 2024

BUY
$102.11 - $135.92 $18,890 - $25,145
185 Added 7.36%
2,698 $346,000
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $8,514 - $10,228
97 Added 4.01%
2,513 $259,000
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $90,849 - $199,340
999 Added 70.5%
2,416 $219,000
Q2 2023

Aug 08, 2023

SELL
$155.98 - $172.65 $25,424 - $28,141
-163 Reduced 10.32%
1,417 $229,000
Q1 2023

May 03, 2023

BUY
$132.34 - $159.14 $1,191 - $1,432
9 Added 0.57%
1,580 $251,000
Q4 2022

Feb 03, 2023

SELL
$102.55 - $135.33 $215,970 - $285,004
-2,106 Reduced 57.27%
1,571 $212,000
Q3 2022

Nov 08, 2022

SELL
$95.28 - $116.93 $34,777 - $42,679
-365 Reduced 9.03%
3,677 $366,000
Q2 2022

Aug 04, 2022

BUY
$103.24 - $121.81 $6,813 - $8,039
66 Added 1.66%
4,042 $450,000
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $24,392 - $29,485
-262 Reduced 6.18%
3,976 $442,000
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $6,423 - $7,844
67 Added 1.61%
4,238 $475,000
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $675 - $852
-8 Reduced 0.19%
4,171 $400,000
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $282,751 - $354,212
4,179 New
4,179 $350,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track 9258 Wealth Management, LLC Portfolio

Follow 9258 Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 9258 Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 9258 Wealth Management, LLC with notifications on news.